Myelodysplastic Syndromes
Mario Cazzola
Abstract
MDS are clonal hematopoietic disorders involving morphologic defects and peripheral-blood cytopenias, with a risk of progression to acute myeloid leukemia. Except for del(5q) MDS, which is responsive to lenalidomide, these disorders are largely managed with supportive care.
Topics & Concepts
LenalidomideMyelodysplastic syndromesMyeloid leukemiaMedicineHaematopoiesisPeripheral bloodLeukemiaImmunologyMultiple myelomaBone marrowStem cellBiologyGeneticsAcute Myeloid Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentSarcoma Diagnosis and Treatment